首頁 > 市場調查報告書 > 製藥

個人化醫學

精準醫療市場規模、佔有率及成長分析（依技術、產品、定序技術、給藥途徑、應用、最終用途及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1896805

精準醫療市場規模、佔有率及成長分析（依技術、產品、定序技術、給藥途徑、應用、最終用途及地區分類）－2026-2033年產業預測

Precision Medicine Market Size, Share, and Growth Analysis, By Technology, By Product, By Sequencing Technology, By Route of Administration, By Application, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，精準醫療市場規模將達到 955.5 億美元，到 2025 年將達到 1,109.3 億美元，到 2033 年將達到 3,662 億美元，在預測期（2026-2033 年）內，複合年成長率為 16.1%。

精準醫療正在革新醫療保健，它認知到，即使患有同一種疾病，患者也會因遺傳因素、症狀和環境影響等多種因素而產生不同的治療反應。這種方法將泛組學和系統生物學整合到診斷過程中，以便更好地了解每位患者獨特的分子特徵，從而製定個人化的治療方案。基於這些見解的標靶治療可以提供更有效的治療性介入，同時最大限度地減少不必要的治療和成本。基因組學領域的蓬勃發展極大地推動了這一成長，因為人們已經認知到基因定製藥物的潛力。伴隨診斷（利用基因檢測）的重要性日益凸顯，進一步加速了市場擴張。此外，監管機構核准的特藥數量不斷增加，也持續推動精準醫療在臨床實務的應用。

精準醫療市場促進因素

精準醫療市場的發展主要得益於診斷測試的廣泛應用，這些測試用於分析患者的基因譜。這些測試著重於個體差異、基因突變和其他變異。這種方法能夠根據每位患者獨特的基因組成來制定個人化的治療方案。此外，產前檢測和癌症篩檢的日益普及，以及面向消費者的基因檢測的興起，也推動了對基因檢測服務需求的成長。這一趨勢凸顯了醫療解決方案向更個人化的轉變，促進了精準醫療的發展，並改善了患者的治療效果。

限制精準醫療市場的因素

精準醫療市場面臨嚴峻的挑戰，這源自於個人基因和健康數據的廣泛收集和分析所帶來的重大隱私和安全問題。敏感資訊外洩或濫用的可能性構成真正的威脅，並可能削弱患者對醫療服務提供者和研究人員的信任。這種擔憂不僅影響個人共用個人資料的意願，也引發了精準醫療解決方案應用相關倫理挑戰的日益激烈的討論。如果這些隱私和安全問題持續存在，它們可能會阻礙精準醫療領域創新方法的開發和廣泛應用。

精準醫療市場趨勢

隨著醫療保健越來越受到基因資訊的影響，並朝著個人化治療方向發展，精準醫療市場正經歷著變革性的趨勢。關鍵發展包括將基因檢測和分子診斷整合到臨床實踐中，從而能夠制定更個人化的治療方案，以適應每位患者的個別情況。 DNADNA測序技術和分子譜分析的進步正在改善疾病的診斷和管理，進而提升患者的治療效果。隨著醫療服務提供者積極採用這些創新技術，標靶治療也日益受到重視，這進一步鞏固了精準醫療在以更高的療效和特異性應對複雜疾病方面的作用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Hoffmann-La Roche Ltd.（Switzerland）
Novartis AG（Switzerland）
Pfizer Inc.（US）
Bristol Myers Squibb（US）
AstraZeneca（UK）
Almac Group Ltd.（UK）
Gilead Sciences, Inc.（US）
AbbVie Inc.（US）
Eli Lilly and Company（US）
GlaxoSmithKline plc（UK）
Ab-Biotics Sa（USA）
Johnson & Johnson（US）
Merck KGaA（Germany）
Amgen, Inc.（US）

結論與建議

簡介目錄

Product Code: SQMIG35B2061

Precision Medicine Market size was valued at USD 95.55 Billion in 2024 and is poised to grow from USD 110.93 Billion in 2025 to USD 366.2 Billion by 2033, growing at a CAGR of 16.1% during the forecast period (2026-2033).

Precision medicine revolutionizes healthcare by recognizing that individuals with identical conditions may respond differently due to various factors, including genetics, symptoms, and environmental influences. This approach facilitates customized treatment plans by enhancing the understanding of each patient's unique molecular profile, often integrating panomics and systems biology in the diagnostic process. Targeted therapies derived from these insights provide more effective interventions while minimizing unnecessary treatments and costs. The burgeoning field of genomics significantly contributes to this growth, as the potential of genetically tailored medications gains recognition. The rising importance of companion diagnostics, which employ genetic testing, further accelerates market expansion. Additionally, an increasing number of specialized medications approved by regulatory bodies continues to drive precision medicine's adoption in clinical practice.

Top-down and bottom-up approaches were used to estimate and validate the size of the Precision Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Precision Medicine Market Segments Analysis

Global Precision Medicine Market is segmented by Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use and region. Based on Technology, the market is segmented into Bioinformatics, Big Data Analytics, Drug Discovery, Gene Sequencing, Companion Diagnostics and Others. Based on Product, the market is segmented into Consumables, Instruments and Services. Based on Sequencing Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing. Based on Route of Administration, the market is segmented into Oral, Injectable, By Drugs, Alectinib, Osimertinib, Mepolizumab, Aripiprazole Lauroxil and Others. Based on Application, the market is segmented into CNS, Immunology, Oncology, Respiratory and Others. Based on End-Use, the market is segmented into Diagnostic Companies, Pharmaceutical Companies, Healthcare IT companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Precision Medicine Market

The Precision Medicine market is significantly driven by the extensive application of diagnostic tests that analyze a patient's genetic profile, focusing on individual variations, genetic mutations, and other differences. This approach enables the development of tailored treatment plans that cater specifically to each patient's unique genetic makeup. Furthermore, the growing accessibility of prenatal and cancer screening tests, along with the rise of direct-to-consumer genetic testing, is contributing to the increasing demand for genetic testing services. This trend highlights a shift towards more personalized healthcare solutions, fostering advancements in precision medicine and improving patient outcomes.

Restraints in the Precision Medicine Market

The Precision Medicine market faces notable challenges due to significant privacy and security issues associated with the extensive collection and analysis of personal genetic and health data. The potential for sensitive information to be compromised or misused poses a real threat, jeopardizing the trust that patients place in healthcare providers and researchers. This concern not only affects individual willingness to share personal data but also contributes to a growing debate surrounding the ethical implications of utilizing precision medicine solutions. As these privacy and security apprehensions persist, they may hinder the advancement and adoption of innovative approaches in the field of precision medicine.

Market Trends of the Precision Medicine Market

The Precision Medicine market is experiencing a transformative trend as healthcare shifts towards personalized treatment methodologies, significantly influenced by genetic insights. Key developments include the integration of genetic testing and molecular diagnostics into clinical practice, allowing for more tailored treatment plans that cater to individual patient profiles. Advances in DNA sequencing technology and molecular profiling are enhancing disease diagnosis and management, leading to improved patient outcomes. As healthcare providers increasingly embrace these innovations, a growing emphasis on targeted therapies is observed, further solidifying the role of precision medicine in addressing complex diseases with greater efficacy and specificity.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Precision Medicine Market Size by Technology & CAGR (2026-2033)

Market Overview
Bioinformatics
Big Data Analytics
Drug Discovery
Gene Sequencing
Companion Diagnostics
Others

Global Precision Medicine Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
Instruments
Services

Global Precision Medicine Market Size by Sequencing Technology & CAGR (2026-2033)

Market Overview
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Chain Termination Sequencing
Nanopore Sequencing

Global Precision Medicine Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Oral
Injectable
By Drugs
Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil
Others

Global Precision Medicine Market Size by Application & CAGR (2026-2033)

Market Overview
CNS
Immunology
Oncology
Respiratory
Others

Global Precision Medicine Market Size by End-Use & CAGR (2026-2033)

Market Overview
Diagnostic Companies
Pharmaceutical Companies
Healthcare IT companies
Others

Global Precision Medicine Market Size & CAGR (2026-2033)

North America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- US
- Canada
Europe (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product, Sequencing Technology, Route of Administration, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ab-Biotics Sa (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments